Skip to main content

Table 3 Criteria for plan validation

From: Dosimetric comparison between helical tomotherapy and volumetric modulated arc-therapy for non-anaplastic thyroid cancer treatment

Structures

Dose-constraint

PTV 63 Gy

D50% = 63 Gy

D95% > 95%Dpresc HR

D98% > 90%Dpresc HR

D2% < 107%Dpresc HR

PTV 54 Gy

D95% > 95%Dpresc LR

D98% > 90%Dpresc LR

PRV medullary canal

Dmax < 45Gy

Parotid glands*

Dmean < 26Gy

V15Gy < 65%

V30Gy < 45%

V45Gy < 24%

Mandible

Dmean < 30Gy

Dmax < 70Gy

Larynx

Dmean < 30Gy

Dmax < 55Gy

Oral cavity

Dmean < 30Gy

Dmax < 55Gy

Sub-maxillary glands*

Dmean < 40Gy

  1. *At least one.